Study: MUSE System Reduces PPI Use in 85% of Patients

During the Society of American Gastrointestinal and Endoscopy Surgeons 2014 meeting, Medigus presented a study on its MUSE system.

The study examined the system's efficacy as a trans-oral treatment for gastroesophageal reflux disease. The study found:

•    85 percent of GERD patients reduced proton pump inhibitor use by 50 percent or more
•    Of these patients, 65 percent were able to eliminate medication use after six months
•    73 percent of patients reported improved quality of life scores of 50 percent or more

More Articles on Gastroenterology:
Adenoma Detection Rate: Lowering Colorectal Cancer Risk
12 Gastroenterologist Moves & Honors
Defining Leadership in the GI Field: 2 Gastroenterologists Discuss Their Strategies

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast